This document is meant to provide an overview on European Commission funding in support of health.
European Commission funding opportunities in support of health
English (265.7 KB - PDF)An agency of the European Union
Frequent searches:
This document is meant to provide an overview on European Commission funding in support of health.
European Commission funding opportunities in support of health
English (265.7 KB - PDF)
In 2024, 5 856 confirmed cases of invasive Haemophilus influenzae disease were reported in the EU/EEA.
Haemophilus influenzae disease - Annual Epidemiological Report for 2024
English (912.19 KB - PDF)
Since May 2026, an Ebola virus disease outbreak caused by Bundibugyo virus has been ongoing in the Democratic Republic of the Congo (DRC).
To make this site work properly, we sometimes place small data files called cookies on your device.
The aim of this report is to assess the current situation regarding availability and access to prevention, testing, and treatment services for migrant populations in the EU/EEA regarding HIV, TB, hepatitis, and STI, based on disease monitoring data collected by ECDC in 2024–2025.
Prevention, testing and treatment services for migrant populations in relation to HIV, tuberculosis, viral hepatitis and sexually transmitted infections
English (573.34 KB - PDF)
This report identifies practice-based evidence within models of care that improve testing, linkage to care, and/or retention in care for HIV, tuberculosis, viral hepatitis B and C and/or sexually transmitted infections among migrant populations in the European Union (EU) and European Economic Area (EEA). It highlights approaches that have had an impact in real-world settings, especially those that address the specific needs and barriers faced by migrant populations.
From evidence to practice – successful models for improved testing, linkage to and retention in care for migrant populations, related to HIV, TB, viral hepatitis and STIs in the EU/EEA
English (2.65 MB - PDF)
Migrant populations often face unique and intersecting barriers that can delay diagnosis and interrupt continuity of care, including language differences, cultural and health literacy gaps, uncertain legal status, stigma, and limited familiarity with healthcare systems.
Evidence brief: From evidence to practice – successful models for improved testing, linkage to and retention in care for migrant populations, related to HIV, TB, viral hepatitis and STIs in the EU/EEA
English (2.36 MB - PDF)
This report gives an overview of the countries and areas where dengue cases – and their corresponding case numbers - have been reported to the European surveillance portal for infectious diseases (EpiPulse).
Update providing weekly overview of the countries and areas where chikungunya virus disease cases have been reported.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 September, and includes updates on respiratory virus epidemiology in the EU/EEA Ebola, ECDC expert deployment, West Nile Virus, Crimean-Congo haemorrhagic fever, dengue, chikungunya, and vibrio risk in coastal waters.
Communicable disease threats report, 19-25 September, week 39
English (2.91 MB - PDF)
This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
The likelihood of onward transmission of dengue virus in mainland Europe is linked to importation of the virus by viraemic travellers into receptive areas with established and active competent mosquito vectors (e.g. Aedes albopictus and Aedes aegypti).
Prof Michael Borg, Infection Prevention and Control Lead at Mater Dei Hospital in Malta, shares his experience of using hyFive, ECDC’s digital hand hygiene monitoring tool.
Weekly updates with the latest reports on West Nile virus cases in Europe updated every Friday, during the transmission season.
Weekly updated overview of reported Crimean-Congo haemorrhagic fever (CCHF) in the EU/EEA countries and areas.
The European Centre for Disease Prevention and Control (ECDC), in collaboration with the European AIDS Clinical Society (EACS), has developed standards of HIV care that define key quality statements, indicators and targets to support improvements in, access to, and quality of HIV services.
Audit of standards of care for HIV testing
English (963.32 KB - PDF)
The human immunodeficiency virus (HIV) remains one of the most important communicable diseases in Europe. It is an infection associated with serious disease, persistently high costs of treatment and care, significant number of deaths and shortened life expectancy.
The global community has committed to eliminating vertical transmission of HIV, hepatitis B virus (HBV) and syphilis as a public health priority. This global commitment encourages countries to provide the most effective, high-quality and person-centred care available to pregnant and breastfeeding people, aiming to ensure a generation born free of HIV, syphilis and HBV.
European Standards of prevention and care: Module on Antenatal Screening for HIV, hepatitis B and syphilis
English (1.44 MB - PDF)
ECDC: on Air - Episode 79 - A. Genath & L. Adamíková - Learning In The Field: 7 Weeks In South Sudan
To mark World Field Epidemiology Day, Antonia Genath and Linda Adamíková share their experience of a seven-week deployment to South Sudan, where they supported Ebola preparedness and surveillance activities alongside WHO, local health authorities and other partners.
The Advisory Forum advises the Director of the Centre on the quality of the scientific work undertaken by ECDC.
Basic facts about Ebola virus disease, including symptoms, treatment, vaccines, and precautions.
Between 5 June and 28 August 2026, 110 highly pathogenic avian influenza (HPAI) A(H5N1) virus detections were reported in domestic (7) and wild (103) birds in 12 countries in Europe.
Avian influenza overview June–August 2026
English (2.85 MB - PDF)
This guide provides a harmonised, non-prescriptive framework for data collection on doxycycline prophylaxis for the prevention of bacterial sexually transmitted infections (STIs) in the European Union/European Economic Area (EU/EEA).
Doxycycline prophylaxis for bacterial sexually transmitted infections: a guide for data collection in the EU/EEA
English (1.58 MB - PDF)